OOIR: Observatory of International Research

Papers

(The H4-Index of Annual Review of Pharmacology and Toxicology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)

Article	Citations
Nanoparticle Toxicology	192
Arsenic: A Global Environmental Challenge	170
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span	167
Preventing and Treating Anthracycline Cardiotoxicity: New Insights	95
Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges	88
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy	84
E-Cigarette Toxicology	79
Thioredoxin Reductase Inhibition for Cancer Therapy	78
A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer	67
Antisense Drugs Make Sense for Neurological Diseases	60
TRP Channel Cooperation for Nociception: Therapeutic Opportunities	60
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors	55
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance	55
Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor	47
Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem	46
Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases	46
Endocrine-Disrupting Chemicals and Child Health	45
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure	44
Oxidative Stress and Metabolism: A Mechanistic Insight for Glyphosate Toxicology	43
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease	42
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders	41
Endocannabinoid-Based Therapies	41
Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics	39
Drugs That Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option	39
The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting	38

CaMKII as a Therapeutic Target in Cardiovascular Disease	37
Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond	36
Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics	36
Store-Operated Ca²⁺ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets	36
G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications	35
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis	35
Artificial Intelligence for Drug Discovery: Are We There Yet?	34
Pharmacologic Approach to Sinoatrial Node Dysfunction	34
Drug Target Identification in Tissues by Thermal Proteome Profiling	34
The Gut Microbiome, Metformin, and Aging	34